BREANNE ST MARTIN: Open Payments
NPI 1053938886 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 33 payments from 9 companies in 2025. Trend: 2023 $993 · 2024 $936 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| Braintree Laboratories, Inc. | 7 | $341 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $131 |
| Janssen Biotech, Inc. | 5 | $130 |
| ABBVIE INC. | 4 | $98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $96 |
| Gilead Sciences, Inc. | 4 | $92 |
| Intercept Pharmaceuticals, Inc. | 2 | $54 |
| Ardelyx, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $16 |
Products named: SUTAB, TREMFYA, XIFAXAN, ENTYVIO, LINZESS, SUFLAVE, OCALIVA, EOHILIA.
Industry payments across RI — which companies pay providers there.
